You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Drug Label Revisions for Two Psychiatric Drugs

Aschenbrenner, Diane S. MS, RN

AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000407286.02007.96
Drug Watch
Abstract

* The daily dosage of the anti-depressant citalopram (Celexa) has now been limited to 40 mg because of potential dose-dependent QT prolongation and the risk of life-threatening arrhythmias.

* The label for the atypical antipsychotic asenapine (Saphris) has been revised to warn of possibly serious allergic reactions, including anaphylaxis and angioedema.

Author Information

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: dianea@son.jhmi.edu.

© 2011 Lippincott Williams & Wilkins, Inc.